−0.65 USD
−13.07 M USD
0.00 USD
16.98 M
About Telomir Pharmaceuticals, Inc.
Sector
CEO
Erez Aminov
Headquarters
Miami
Website
Founded
2021
FIGI
BBG01K4SG3V0
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Miami, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TELO is 4.22 USD — it has increased by 0.72% in the past 24 hours. Watch Telomir Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Telomir Pharmaceuticals, Inc. stocks are traded under the ticker TELO.
TELO stock has risen by 1.93% compared to the previous week, the month change is a −19.47% fall, over the last year Telomir Pharmaceuticals, Inc. has showed a −39.71% decrease.
TELO reached its all-time high on Feb 14, 2024 with the price of 20.72 USD, and its all-time low was 3.11 USD and was reached on Aug 2, 2024. View more price dynamics on TELO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TELO stock is 3.05% volatile and has beta coefficient of 0.16. Track Telomir Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Telomir Pharmaceuticals, Inc. there?
Yes, you can track Telomir Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
TELO net income for the last quarter is −1.45 M USD, while the quarter before that showed −6.25 M USD of net income which accounts for 76.83% change. Track more Telomir Pharmaceuticals, Inc. financial stats to get the full picture.
No, TELO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 9.00 employees. See our rating of the largest employees — is Telomir Pharmaceuticals, Inc. on this list?
Like other stocks, TELO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telomir Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Telomir Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Telomir Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Telomir Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.